SPY+0.17%QQQ+0.03%NVDA+4.01%MSFT+0.05%AAPL−1.27%GOOGL+1.72%META+0.53%AMZN−1.09%TSLA+0.63%AVGO−1.08%SPY+0.17%QQQ+0.03%NVDA+4.01%MSFT+0.05%AAPL−1.27%GOOGL+1.72%META+0.53%AMZN−1.09%TSLA+0.63%AVGO−1.08%
← back to Recession-Resilient US Defensive 20 — Equal-Weighted
Holding

AbbVie Inc.ABBV

Biopharmaceutical leader with $363B market cap, 72% gross margin, and 10% revenue growth. Equal-weighted at 5%; strong drug portfolio including Humira franchise generates substantial free cash flow.

weight · 5.00%·sector · Healthcare

Price

TradingView Advanced Chart

Snapshot

Quote + description

Technical analysis

Oscillators + moving averages

Fundamentals

Revenue / margins / balance sheet

Company profile

News

Ticker-scoped headlines
/home·/markets·/feed·/leaderboard·/blog·/pricing·/about·/vacancies·/contact
⚠Research tool · not financial advice · past performance does not guarantee future results.